Nara Organics recalled its organic baby formula sold nationwide in Target stores and online Saturday after a multistate outbreak of infant botulism, according to federal health authorities. Three babies between 2 and 5 months old became ill in April and May in California, Pennsylvania, and Washington after consuming Nara Organics Whole Milk Organic Powdered infant formula, which is also sold on Nara.com, the U.S. Food and Drug Administration said.
The infants were hospitalized and treated with BabyBIG, the FDA-approved treatment for infant botulism made from blood plasma of people immunized against the toxin. Infant botulism is a rare but serious illness that occurs in babies under age 1 whose gut microbiomes are still developing. The illness occurs when spores of Clostridium botulinum bacteria germinate and produce toxin in the intestines.
What the Left Is Saying
Consumer advocacy groups and Democratic lawmakers who focus on food safety have called for swift action to protect families. Senator Amy Klobuchar of Minnesota, who has championed food safety legislation, said parents deserve transparency and accountability when products marketed to children cause harm. The Centers for Disease Control urged anyone with the formula to stop using it immediately, take a picture of the can noting lot number and use-by date, label it 'DO NOT USE,' and store it safely away from other baby food items for at least a month while monitoring infants for symptoms.
Organizations like the Center for Science in the Public Interest noted that infant formula manufacturers operate under FDA oversight and called for a review of import safety protocols. They argued that products manufactured abroad but sold domestically should meet the same stringent standards as domestic production, with enhanced testing requirements before reaching store shelves.
What the Right Is Saying
Conservative commentators and free-market advocates emphasized that this appears to be an isolated incident rather than a systemic regulatory failure. The FDA confirmed that Nara Organics Whole Milk Organic Infant Formula makes up less than 1 percent of all infant formula sold in the United States, and officials said the outbreak does not create shortage concerns for parents and caregivers.
Industry groups noted that the company's voluntary recall demonstrates the food safety system is functioning as designed, with manufacturers self-reporting and cooperating with federal investigators. Some Republican lawmakers have long argued for streamlined FDA processes that maintain safety standards while reducing regulatory burden on businesses, suggesting this case illustrates the importance of proportionate oversight rather than expanded government intervention.
What the Numbers Show
Three infants were affected across three states — California, Pennsylvania, and Washington — in a two-month period from April through May. The cases involved babies aged 2 to 5 months old. Nara Organics holds less than 1 percent market share of U.S. infant formula sales, meaning millions of American families use alternative products unaffected by the recall. No shortages are anticipated, according to the FDA. Infant botulism affects fewer than 200 babies per year in the United States, making it rare but serious for those who contract it.
Symptoms requiring immediate medical attention include constipation, poor feeding, drooping eyelids, weak muscle tone, difficulty swallowing, and breathing problems. BabyBIG is the sole treatment approved by the FDA for infant botulism. The recalled formula was manufactured in Europe but sold exclusively in the U.S. market at Target locations nationwide and through Nara.com.
The Bottom Line
Federal health officials are urging caregivers to immediately stop using Nara Organics Whole Milk Organic Powdered infant formula and monitor infants for symptoms of botulism, which can be life-threatening if untreated. Parents with questions about the recall or their child's health should contact their pediatrician or call the FDA's information line. The CDC recommends retaining product photos and lot numbers as the investigation continues. Families seeking alternative formulas have numerous options available; officials stress that no supply shortages are expected given Nara Organics' small market footprint.